See more : Guardian Capital Group Limited (GCG.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Jack Nathan Medical Corp. (JNH.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jack Nathan Medical Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- SSR Mining Inc. (SSRM) Income Statement Analysis – Financial Results
- SmartCentres Real Estate Investment Trust (CWYUF) Income Statement Analysis – Financial Results
- Zhejiang Youpon Integrated Ceiling Co.,Ltd. (002718.SZ) Income Statement Analysis – Financial Results
- Vestis Corporation (VSTS) Income Statement Analysis – Financial Results
- Jiangnan Group Limited (1366.HK) Income Statement Analysis – Financial Results
Jack Nathan Medical Corp. (JNH.V)
About Jack Nathan Medical Corp.
Jack Nathan Medical Corp., together with its subsidiaries, operates primary care medical clinics in Walmart Supercentres under the Jack Nathan Health brand. As of June 30, 2022, it operated 76 clinics in Walmart locations in Canada, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario,and Quebec, as well as 4 clinics outside Walmart; and 18 medical clinics, 2 Rehab, and 5 MedSpa; and 108 corporate owned and operated clinics in Walmart locations in Mexico. Jack Nathan Medical Corp. was founded in 2006 and is headquartered in Woodbridge, Canada.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 19.14M | 15.49M | 3.85M | 3.85M | 0.00 | 0.00 |
Cost of Revenue | 4.67M | 3.67M | 74.43K | 74.43K | 0.00 | 0.00 |
Gross Profit | 14.48M | 11.82M | 3.78M | 3.78M | 0.00 | 0.00 |
Gross Profit Ratio | 75.62% | 76.31% | 98.07% | 98.07% | 0.00% | 0.00% |
Research & Development | 0.00 | 236.93K | 102.00K | 102.00K | 0.00 | 0.00 |
General & Administrative | 17.38M | 15.56M | 4.16M | 134.62K | 0.00 | 18.09K |
Selling & Marketing | 466.23K | 260.82K | 243.64K | 243.64K | 0.00 | 0.00 |
SG&A | 18.50M | 15.82M | 4.41M | 134.62K | 102.87K | 18.09K |
Other Expenses | 2.42M | 0.00 | -72.76K | -72.76K | 0.00 | 0.00 |
Operating Expenses | 20.92M | 17.12M | 4.65M | 134.62K | 102.87K | 18.09K |
Cost & Expenses | 25.59M | 20.79M | 4.73M | 134.62K | 102.87K | 18.09K |
Interest Income | 0.00 | 12.15K | 16.15K | 16.15K | 0.00 | 0.00 |
Interest Expense | 0.00 | 409.52K | 36.24K | 36.24K | 0.00 | 0.00 |
Depreciation & Amortization | 1.18M | 1.07M | 516.12K | 144.84K | 144.84K | 171.86K |
EBITDA | -4.95M | -5.51M | -7.54M | -10.11M | 196.26K | 778.25K |
EBITDA Ratio | -25.88% | -26.30% | -20.46% | -3.49% | 0.00% | 0.00% |
Operating Income | -6.44M | -5.14M | -1.35M | -134.62K | -102.87K | -18.09K |
Operating Income Ratio | -33.66% | -33.21% | -35.16% | -3.49% | 0.00% | 0.00% |
Total Other Income/Expenses | -997.72K | -1.85M | -725.88K | -8.94M | -31.75K | 2.80M |
Income Before Tax | -7.44M | -6.99M | -10.29M | -134.62K | -134.62K | -18.09K |
Income Before Tax Ratio | -38.87% | -45.12% | -267.23% | -3.49% | 0.00% | 0.00% |
Income Tax Expense | -805.84K | -85.97K | -380.92K | -380.92K | -206.30K | -171.86K |
Net Income | -6.64M | -7.08M | -9.91M | -134.62K | -134.62K | -18.09K |
Net Income Ratio | -34.66% | -45.69% | -257.34% | -3.49% | 0.00% | 0.00% |
EPS | -0.08 | -0.08 | -0.12 | 0.00 | -0.13 | -0.01 |
EPS Diluted | -0.08 | -0.08 | -0.12 | 0.00 | -0.13 | -0.01 |
Weighted Avg Shares Out | 85.53M | 84.30M | 82.23M | 51.63M | 1.00M | 2.63M |
Weighted Avg Shares Out (Dil) | 85.53M | 84.30M | 82.23M | 51.63M | 1.00M | 2.63M |
Source: https://incomestatements.info
Category: Stock Reports